Larger temporal volume in elderly with high versus low beta-amyloid deposition
Abstract
β-Amyloid deposition is one of the main hallmarks of Alzheimer's disease thought to eventually cause neuronal death. Post-mortem and neuroimaging studies have consistently reported cases with documented normal cognition despite high β-amyloid burden. It is of great interest to understand what differentiates these particular subjects from those without β-amyloid deposition or with both β-amyloid deposition and cognitive deficits, i.e. what allows these subjects to resist the damage of the pathological lesions. [¹¹C]Pittsburgh compound B positron emission tomography and magnetic resonance brain scans were obtained in 149 participants including healthy controls and patients with subjective cognitive impairment, mild cognitive impairment and Alzheimer's disease. Magnetic resonance data were compared between high versus low-[11C]Pittsburgh compound B cases, and between high-[¹¹C]Pittsburgh compound B cases with versus those without cognitive deficits. Larger temporal (including hippocampal) grey matter volume, associated with better episodic memory performance, was found in high- versus low-[¹¹C]Pittsburgh compound B healthy controls. The same finding was obtained using different [¹¹C]Pittsburgh compound B thresholds, correcting [¹¹C]Pittsburgh compound B data for partial averaging, using age, education, Mini-Mental State Examination, apolipoprotein E4 and sex-matched subsamples, and using manual hippocampal delineation instead of voxel-based analysis. By contrast, in participants with subjective cognitive impairment, significant grey matter atrophy was found in high-[¹¹C]Pittsburgh compound B cases compared to low-[¹¹C]Pittsburgh compound B cases, as well as in high-[¹¹C]Pittsburgh compound B cases with subjective cognitive impairment, mild cognitive impairment and Alzheimer's disease compared to high-[¹¹C]Pittsburgh compound B healthy controls. Larger grey matter volume in high-[¹¹C]Pittsburgh compound B healthy controls may reflect either a tissue reactive response to β-amyloid or a combination of higher 'brain reserve' and under-representation of subjects with standard/low temporal volume in the high-[¹¹C]Pittsburgh compound B healthy controls. Our complementary analyses tend to support the latter hypotheses. Overall, our findings suggest that the deleterious effects of β-amyloid on cognition may be delayed in those subjects with larger brain (temporal) volume.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In participants with subjective cognitive decline, individuals with a higher level of amyloid deposition show significant gray matter atrophy compared with individuals with a low level of amyloid deposition.
“A between-group analysis performed by Chetelat et al. indicated that, in participants with SCD, individuals with a higher level of amyloid deposition showed significant gray matter atrophy compared with individuals with a low level of amyloid deposition [180].”
From Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease (2020) · cites this paper as [180]
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676 · see citing works
A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains
Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N. A., Friston, K. J., & Frackowiak, R. S. J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0786 · Cited by 4,561 · see citing works
Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., & Peck, A. (1988) · Annals of Neurology · doi:10.1002/ana.410230206 · Cited by 1,225 · see citing works
Dickerson, B. C., Bakkour, A., Salat, D. H., Feczko, E., Pacheco, J., Greve, D. N., Grodstein, F., Wright, C. I., Blacker, D., Rosas, H. D., et al. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn113 · Cited by 1,153 · see citing works
[ <sup>11</sup> C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036 · see citing works
Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987 · see citing works
Ellis, K. A., Bush, A. I., Darby, D., Fazio, D. D., Foster, J. K., Hudson, P. J., Lautenschlager, N. T., Lenzo, N. P., Martins, R. N., Maruff, P. T., et al. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209009405 · Cited by 970 · see citing works
Self-citationJack, C. R., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., Knopman, D. S., Boeve, B. F., Klunk, W. E., Mathis, C. A., et al. (2008) · Brain · doi:10.1093/brain/awm336 · Cited by 958 · see citing works
Mild Cognitive Impairment as a Clinical Entity and Treatment Target
Petersen, R. C., & Morris, J. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1160 · Cited by 935 · see citing works
Cognitive Reserve and Alzheimer Disease
Stern, Y. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213815.20177.19 · Cited by 838 · see citing works
Pike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C. L., & Rowe, C. C. (2007) · Brain · doi:10.1093/brain/awm238 · Cited by 789 · see citing works
Self-citationReiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785 · see citing works
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
Mormino, E. C., Kluth, J. T., Madison, C. M., Rabinovici, G. D., Baker, S. L., Miller, B. L., Koeppe, R. A., Mathis, C. A., Weiner, M. W., Jagust, W. J., et al. (2009) · Brain · doi:10.1093/brain/awn320 · Cited by 684 · see citing works
Crystal, H., Dickson, D., Fuld, P., Masur, D., Scott, R., Mehler, M., Masdeu, J., Kawas, C., Aronson, M., & Wolfson, L. (1988) · Neurology · doi:10.1212/wnl.38.11.1682 · Cited by 586 · see citing works
Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
Fox, N. C., Black, R. S., Gilman, S., Rossor, M. N., Griffith, S. G., Jenkins, L., & Koller, M. (2005) · Neurology · doi:10.1212/01.wnl.0000159743.08996.99 · Cited by 550 · see citing works
Education modifies the relation of AD pathology to level of cognitive function in older persons
Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Mendes de Leon, C. F., Arnold, S. E., Barnes, L. L., & Bienias, J. L. (2003) · Neurology · doi:10.1212/01.wnl.0000069923.64550.9f · Cited by 549 · see citing works
Edison, P., Archer, H. A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.001 · Cited by 513 · see citing works
Development of dementing illnesses in an 80‐year‐old volunteer cohort
Katzman, R., Aronson, M., Fuld, P. A., Kawas, C. H., Brown, T., Morgenstern, H., Frishman, W. H., Gidez, L. I., Eder, H., & Ooi, W. L. (1989) · Annals of Neurology · doi:10.1002/ana.410250402 · Cited by 453 · see citing works
Cognition, reserve, and amyloid deposition in normal aging
Rentz, D. M., Locascio, J. J., Becker, J. A., Moran, E. K., Eng, E., Buckner, R. L., Sperling, R. A., & Johnson, K. A. (2009) · Annals of Neurology · doi:10.1002/ana.21904 · Cited by 395 · see citing works
Solé‐Padullés, C., Bartrés‐Faz, D., Junqué, C., Vendrell, P., Rami, L., Clemente, I. C., Bosch, B., Villar, A., Bargalló, N., Jurado, M. Á., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.008 · Cited by 387 · see citing works
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
Chételat, G., Villemagne, V. L., Bourgeat, P., Pike, K. E., Jones, G., Ames, D., Ellis, K. A., Szoeke, C., Martins, R. N., O'Keefe, G. J., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21955 · Cited by 373 · see citing works
Self-citation“Preclinical” AD revisited: Neuropathology of cognitively normal older adults
Schmitt, F. A., Davis, D. G., Wekstein, D. R., Smith, C. D., Ashford, J. W., & Markesbery, W. R. (2000) · Neurology · doi:10.1212/wnl.55.3.370 · Cited by 369 · see citing works
Microglial activation and amyloid deposition in mild cognitive impairment: A PET study
Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338622.27876.0d · Cited by 367 · see citing works
Storandt, M., Mintun, M. A., Head, D. M., & Morris, J. C. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.272 · Cited by 304 · see citing works
Abdulrab, K., & Heun, R. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.02.004 · Cited by 292 · see citing works
Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics
Masters, C. L., Cappai, R., Barnham, K. J., & Villemagne, V. L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03989.x · Cited by 237 · see citing works
Self-citationBourgeat, P., Chételat, G., Villemagne, V. L., Fripp, J., Raniga, P., Pike, K., Acosta, O., Szoeke, C., Ourselin, S., Ames, D., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181c918b5 · Cited by 220 · see citing works
Self-citationIacono (2009) · doi:10.1212/wnl.0b013e3181b01077 · Cited by 203 · see citing works
Vitamin B 12 status and rate of brain volume loss in community-dwelling elderly
Vogiatzoglou, A., Refsum, H., Johnston, C., Smith, S. M., Bradley, K. M., de Jager, C., Budge, M. M., & Smith, A. D. (2008) · Neurology · doi:10.1212/01.wnl.0000325581.26991.f2 · Cited by 192 · see citing works
Archer, H. A., Edison, P., Brooks, D. J., Barnes, J., Frost, C. D., Yeatman, T., Fox, N. C., & Rossor, M. N. (2006) · Annals of Neurology · doi:10.1002/ana.20889 · Cited by 179 · see citing works
Mori, E., Hirono, N., Yamashita, H., Imamura, T., Ikejiri, Y., Ikeda, M., Kitagaki, H., Shimomura, T., & Yoneda, Y. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.1.18 · Cited by 170 · see citing works
Factors associated with resistance to dementia despite high Alzheimer disease pathology
Erten‐Lyons, D., Woltjer, R. L., Dodge, H. H., Nixon, R. A., Vorobik, R., Calvert, J. F., Leahy, M., Montine, T. J., & Kaye, J. A. (2009) · Neurology · doi:10.1212/01.wnl.0000341273.18141.64 · Cited by 148 · see citing works
Fjell, A. M., Walhovd, K. B., Reinvang, I., Lundervold, A., Salat, D. H., Quinn, B. T., Fischl, B. R., & Dale, A. M. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.08.007 · Cited by 123 · see citing works
Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons
Riudavets, M. A., Iacono, D., Resnick, S. M., O’Brien, R., Zonderman, A. B., Martin, L. J., Rudow, G., Pletnikova, O., & Troncoso, J. C. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.005 · Cited by 106 · see citing works
Mevel, K., Desgranges, B., Baron, J., Landeau, B., Sayette, V. D. L., Viader, F., Eustache, F., & Chételat, G. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.04.048 · Cited by 87 · see citing works
Self-citationFathallah‐Shaykh, H. M. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.19 · Cited by 69 · see citing works
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Flagged first, then by citations
1 of the 41 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Jessen, F., Amariglio, R. E., van Boxtel, M., Breteler, M., Ceccaldi, M., Chételat, G., Dubois, B., Dufouil, C., Ellis, K. A., van der Flier, W. M., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.01.001 · Cited by 3,014 · see citing works
Self-citationThe Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Liu, E., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1769 · Cited by 1,011 · see citing works
Fjell, A. M., McEvoy, L., Holland, D., Dale, A. M., & Walhovd, K. B. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.004 · Cited by 799 · see citing works
The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
Sperling, R., Mormino, E., & Johnson, K. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.038 · Cited by 725 · see citing works
β-Amyloid burden in healthy aging: Regional distribution and cognitive consequences
Rodrigue, K. M., Kennedy, K. M., Devous, M. D., Rieck, J. R., Hebrank, A. C., Diaz-Arrastia, R., Mathews, D., & Park, D. C. (2012) · Neurology · doi:10.1212/wnl.0b013e318245d295 · Cited by 419 · see citing works
Chételat, G., Joie, R. L., Villain, N., Perrotin, A., Sayette, V. D. L., Eustache, F., & Vandenberghe, R. R. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.02.006 · Cited by 353 · see citing works
Self-citationWeiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Cedarbaum, J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.001 · Cited by 348 · see citing works
Mormino, E. C., Betensky, R. A., Hedden, T., Schultz, A. P., Amariglio, R. E., Rentz, D. M., Johnson, K. A., & Sperling, R. A. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2031 · Cited by 328 · see citing works
Accelerating Cortical Thinning: Unique to Dementia or Universal in Aging?
Fjell, A. M., Westlye, L. T., Grydeland, H., Amlien, I. K., Espeseth, T., Reinvang, I., Raz, N., Dale, A. M., Walhovd, K. B., & Initiative, A. D. N. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs379 · Cited by 306 · see citing works
Arenaza‐Urquijo, E. M., Landeau, B., Joie, R. L., Mevel, K., Mézenge, F., Perrotin, A., Desgranges, B., David Bartrés-faz, A., Eustache, F., & Chételat, G. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.06.053 · Cited by 291 · see citing works
Self-citationNeuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease
Wang, X., Huang, W., Su, L., Xing, Y., Jessen, F., Sun, Y., Shu, N., & Han, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00395-3 · Cited by 265 · see citing works
Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment
Scheef, L., Spottke, A., Daerr, M., Joe, A., Striepens, N., Kölsch, H., Popp, J., Daamen, M., Gorris, D., Heneka, M. T., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826c1a8d · Cited by 277 · see citing works
Putcha, D., Brickhouse, M. J., O’Keefe, K., Sullivan, C., Rentz, D. M., Marshall, G. A., Dickerson, B. C., & Sperling, R. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4740-11.2011 · Cited by 258 · see citing works
Lifespan brain activity, β-amyloid, and Alzheimer's disease
Jagust, W. J., & Mormino, E. C. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.09.004 · Cited by 221 · see citing works
Amyloid burden and neural function in people at risk for Alzheimer's Disease
Johnson, S. C., Christian, B. T., Okonkwo, O. C., Oh, J. M., Harding, S., Xu, G., Hillmer, A. T., Wooten, D. W., Murali, D., Barnhart, T. E., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.028 · Cited by 218 · see citing works
Cortical microstructural changes along the Alzheimer’s disease continuum
Montal, V., Vilaplana, E., Alcolea, D., Pegueroles, J., Pasternak, O., González‐Ortiz, S., Clarimón, J., Carmona‐Iragui, M., Illán‐Gala, I., Morenas‐Rodríguez, E., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.013 · Cited by 204 · see citing works
David Bartrés-faz, A., & Arenaza‐Urquijo, E. M. (2011) · Brain Topography · doi:10.1007/s10548-011-0195-9 · Cited by 176 · see citing works
Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition
Chételat, G., Villemagne, V. L., Villain, N., Jones, G. R., Ellis, K. A., Ames, D. J., Martins, R. N., Masters, C. L., & Rowe, C. C. (2012) · Neurology · doi:10.1212/wnl.0b013e318246d67a · Cited by 172 · see citing works
Self-citationCognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease
Arenaza-Urquijo, E., Wirth, M., & Chételat, G. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00134 · Cited by 153 · see citing works
Self-citationChételat, G., Villemagne, V. L., Pike, K. E., Ellis, K. A., Bourgeat, P., Jones, G. R., O'Keefe, G. J., Salvado, O., Szoeke, C. E. I., Martins, R. N., et al. (2011) · Brain · doi:10.1093/brain/awq383 · Cited by 153 · see citing works
Self-citationIncreased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1‐42
Schott, J. M., Bartlett, J. W., Fox, N. C., Barnes, J., & Initiative, A. D. N. (2010) · Annals of Neurology · doi:10.1002/ana.22315 · Cited by 145 · see citing works
Fortea, J., Vilaplana, E., Alcolea, D. A., Carmona‐Iragui, M., Sánchez‐Saudinós, M., Sala, I., Antón‐Aguirre, S., González‐Ortiz, S., Medrano, S., Pegueroles, J., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24186 · Cited by 143 · see citing works
Cacciaglia, R., Molinuevo, J. L., Falcón, C., Brugulat‐Serrat, A., Sánchez‐Benavides, G., Gramunt, N., Esteller, M., Morán, S., Minguillón, C., Fauria, K., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.01.016 · Cited by 124 · see citing works
Does bilingualism contribute to cognitive reserve? Cognitive and neural perspectives.
Guzmán‐Vélez, E., & Tranel, D. (2014) · Neuropsychology · doi:10.1037/neu0000105 · Cited by 125 · see citing works
Parker, T. D., Slattery, C. F., Zhang, J., Nicholas, J. M., Paterson, R. W., Foulkes, A. J. M., Malone, I. B., Thomas, D. L., Modat, M., Cash, D. M., et al. (2018) · Human Brain Mapping · doi:10.1002/hbm.24056 · Cited by 122 · see citing works
Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease
Teipel, S. J., Heinsen, H., Amaro, E., Grinberg, L. T., Krause, B. J., & Grothe, M. J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.029 · Cited by 111 · see citing works
Fortea, J., Sala‐Llonch, R., David Bartrés-faz, A., Lladó, A., Solé‐Padullés, C., Bosch, B., Antonell, A., Olives, J., Sánchez‐Valle, R., Molinuevo, J. L., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.017 · Cited by 111 · see citing works
Longitudinal brain structural changes in preclinical Alzheimer's disease
Pegueroles, J., Vilaplana, E., Montal, V., Sampedro, F., Alcolea, D. A., Carmona‐Iragui, M., Clarimón, J., Blesa, R., Lleó, A., Fortea, J., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.08.010 · Cited by 109 · see citing works
Detectable Neuropsychological Differences in Early Preclinical Alzheimer’s Disease: A Meta-Analysis
Han, S. D., Nguyen, C. P., Stricker, N. H., & Nation, D. A. (2017) · Neuropsychology Review · doi:10.1007/s11065-017-9345-5 · Cited by 108 · see citing works
Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects
Grothe, M. J., Ewers, M., Krause, B. J., Heinsen, H., & Teipel, S. J. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.09.011 · Cited by 105 · see citing works
Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects
Knopman, D. S., Lundt, E. S., Therneau, T. M., Vemuri, P., Lowe, V. J., Kantarci, K., Gunter, J. L., Senjem, M. L., Mielke, M. M., Machulda, M. M., et al. (2019) · Brain · doi:10.1093/brain/awz025 · Cited by 100 · see citing works
Arenaza‐Urquijo, E. M., Bejanin, A., Gonneaud, J., Wirth, M., Joie, R. L., Mutlu, J., Gaubert, M., Landeau, B., Sayette, V. D. L., Eustache, F., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.016 · Cited by 94 · see citing works
Self-citationSubjective cognitive decline: preclinical manifestation of Alzheimer’s disease
Lin, Y., Shan, P., Jiang, W., Sheng, C., & Ma, L. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3620-y · Cited by 93 · see citing works
A review of β-amyloid neuroimaging in Alzheimer's disease
Adlard, P. A., Tran, B. A., Finkelstein, D. I., Desmond, P. M., Johnston, L. A., Bush, A. I., & Egan, G. F. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00327 · Cited by 93 · see citing works
Ingala, S., de Boer, C., Masselink, L. A., Vergari, I., Lorenzini, L., Blennow, K., Chételat, G., Perri, C. D., Ewers, M., van der Flier, W. M., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12292 · Cited by 93 · see citing works
Self-citationUnbiased comparison of sample size estimates from longitudinal structural measures in ADNI
Holland, D., McEvoy, L. K., Dale, A. M., & Initiative, T. A. D. N. (2011) · Human Brain Mapping · doi:10.1002/hbm.21386 · Cited by 83 · see citing works
A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers
Lawrence, E., Vegvari, C., Ower, A. K., Hadjichrysanthou, C., de Wolf, F., & Anderson, R. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170261 · Cited by 84 · see citing works
Association of Gray Matter Atrophy with Age, β-Amyloid, and Cognition in Aging
Oh, H., Madison, C. M., Villeneuve, S., Markley, C., & Jagust, W. J. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht017 · Cited by 81 · see citing works
Chételat, G. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179920 · Cited by 79 · see citing works
Self-citationTosun, D., Veitch, D. P., Aisen, P. S. S., Jack, C. R., Jagust, W. J., Petersen, R. C., Saykin, A. J., Bollinger, J., Ovod, V., Mawuenyega, K. G., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab008 · Cited by 85 · see citing works
Griesbach, G. S., Masel, B. E., Helvie, R. E., & Ashley, M. J. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2017.5103 · Cited by 77 · see citing works
de Vries, L. E., Huitinga, I., Kessels, H. W. H. G., Swaab, D. F., & Verhaagen, J. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00719-7 · Cited by 82 · see citing works
Understanding the cause of sporadic Alzheimer’s disease
Zetterberg, H., & Mattsson, N. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.915740 · Cited by 73 · see citing works
Emerging β-amyloid pathology and accelerated cortical atrophy
Mattsson, N., Insel, P. S., Nosheny, R., Tosun, D., Trojanowski, J. Q., Shaw, L. M., Jack, C. R., Donohue, M. C., & Weiner, M. W. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.446 · Cited by 71 · see citing works
Distinct effects of beta‐amyloid and tau on cortical thickness in cognitively healthy older adults
Harrison, T. M., Du, R., Klencklen, G., Baker, S. L., & Jagust, W. J. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12249 · Cited by 69 · see citing works
Amyloid imaging: Past, present and future perspectives
Villemagne, V. L. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.005 · Cited by 64 · see citing works
Self-citationAmyloid Imaging with PET in Early Alzheimer Disease Diagnosis
Rowe, C. C., & Villemagne, V. L. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.12.017 · Cited by 61 · see citing works
Self-citationTraumatic brain injury and reserve
Bigler, E. D., & Stern, Y. (2015) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63521-1.00043-1 · Cited by 62 · see citing works
Quejas cognitivas subjetivas: hacia una identificación precoz de la enfermedad de Alzheimer
Ptacek, S. G., Eriksdotter, M., Jelić, V., Porta-Etessam, J., Kåreholt, I., & Palomo, S. M. (2013) · Neurología · doi:10.1016/j.nrl.2013.02.007 · Cited by 60 · see citing works
Gispert, J. D., Rami, L., Sánchez‐Benavides, G., Falcón, C., Tucholka, A., Rojas, S., & Molinuevo, J. L. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.027 · Cited by 56 · see citing works
Biphasic cortical macro‐ and microstructural changes in autosomal dominant Alzheimer's disease
Montal, V., Vilaplana, E., Pegueroles, J., Bejanin, A., Alcolea, D. A., Carmona‐Iragui, M., Clarimón, J., Levin, J., Cruchaga, C., Graff‐Radford, N. R., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12224 · Cited by 54 · see citing works
Wu, Z., Peng, Y. F., Hong, M., & Zhang, Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.593898 · Cited by 54 · see citing works
Song, Z., Insel, P. S., Buckley, S. T., Yohannes, S., Mezher, A. F., Simonson, A., Wilkins, S., Tosun, D., Mueller, S. G., Kramer, J. H., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2092-14.2015 · Cited by 53 · see citing works
Toward a multifactorial model of Alzheimer disease
Storandt, M., Head, D. M., Fagan, A. M., Holtzman, D. M., & Morris, J. C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.029 · Cited by 53 · see citing works
Lee, G. J., Lu, P. H., Medina, L. D., Rodríguez‐Agudelo, Y., Melchor, S. J., Coppola, G., Braskie, M. N., Hua, X., Apostolova, L. G., Leow, A., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-302087 · Cited by 53 · see citing works
Buckley, R. F., Villemagne, V. L., Masters, C. L., Ellis, K. A., Rowe, C. C., Johnson, K. A., Sperling, R. A., & Amariglio, R. E. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0810-z · Cited by 50 · see citing works
Self-citationZolochevska, O., & Taglialatela, G. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160518142110 · Cited by 49 · see citing works
PET imaging of neural activity, β-amyloid, and tau in normal brain aging
Zhang, K., Mizuma, H., Zhang, X., Takahashi, K., Jin, C., Song, F., Gao, Y., Kanayama, Y., Wu, Y., Li, Y., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05230-5 · Cited by 50 · see citing works
Arenaza‐Urquijo, E. M., Molinuevo, J. L., Sala‐Llonch, R., Solé‐Padullés, C., Balasa, M., Bosch, B., Olives, J., Antonell, A., Lladó, A., Sánchez‐Valle, R., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121906 · Cited by 49 · see citing works
Neuroimaging Results Impose New Views on Alzheimer’s Disease—the Role of Amyloid Revised
Fjell, A. M., & Walhovd, K. B. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8228-7 · Cited by 47 · see citing works
Amyloid and Tau Biomarkers in Subjective Cognitive Impairment
Colijn, M. A., & Grossberg, G. T. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150180 · Cited by 48 · see citing works
Neuroimaging biomarkers in Alzheimer’s disease and other dementias
Villemagne, V. L., & Chételat, G. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.004 · Cited by 48 · see citing works
Self-citationSubjective Cognitive Decline and APOE ɛ4: A Systematic Review
Ali, J. I., Smart, C. M., & Gawryluk, J. R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180248 · Cited by 48 · see citing works
Mormino, E. C. (2014) · Neuropsychology Review · doi:10.1007/s11065-014-9267-4 · Cited by 44 · see citing works
Salvadó, G., Shekari, M., Falcón, C., Operto, G., Milà‐Alomà, M., Sánchez‐Benavides, G., Cacciaglia, R., Arenaza‐Urquijo, E. M., Niñerola‐Baizán, A., Perissinotti, A., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac134 · Cited by 45 · see citing works
Kok, F. K., van Leerdam, S., & de Lange, E. C. M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-210607 · Cited by 44 · see citing works
Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials
Andrews, K. A., Marc Modat, A., Macdonald, K. E., Yeatman, T., Cardoso, M. J., Leung, K. K., Barnes, J., Villemagne, V. L., Rowe, C. C., Fox, N. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058816 · Cited by 44 · see citing works
Self-citationAkinyemi, R., Allan, L. M., Oakley, A. E., & Kalaria, R. N. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00717 · Cited by 43 · see citing works
Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings
Braskie, M. N., & Thompson, P. M. (2013) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2013.08.007 · Cited by 44 · see citing works
Sala‐Llonch, R., Idland, A., Borza, T., Watne, L. O., Wyller, T. B., Brækhus, A., Zetterberg, H., Blennow, K., Walhovd, K. B., & Fjell, A. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161146 · Cited by 40 · see citing works
Ye, B. S., Kim, Y. J., Kim, Y. J., Jung, N., Lee, J. S., Lee, J., Jang, Y. K., Yang, J., Lee, J. M., Vogel, J. W., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23676-w · Cited by 41 · see citing works
Evolving brain structural changes in PSEN1 mutation carriers
Sala‐Llonch, R., Lladó, A., Fortea, J., Bosch, B., Antonell, A., Balasa, M., Bargalló, N., David Bartrés-faz, A., Molinuevo, J. L., & Sánchez‐Valle, R. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.022 · Cited by 36 · see citing works
Mielke, M. M., Weigand, S. D., Wiste, H. J., Vemuri, P., Machulda, M. M., Knopman, D. S., Lowe, V. J., Roberts, R. O., Kantarci, K., Rocca, W. A., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.09.001 · Cited by 36 · see citing works
Tardif, C. L., Devenyi, G. A., Amaral, R. S. C., Pelleïeux, S., Poirier, J., Rosa‐Neto, P., Breitner, J. C. S., & Chakravarty, M. M. (2017) · Human Brain Mapping · doi:10.1002/hbm.23897 · Cited by 36 · see citing works
Reseco, L., Atienza, M., Fernandez-Alvarez, M., Carro, E., & Cantero, J. L. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00891-8 · Cited by 33 · see citing works
Should We Disclose Amyloid Imaging Results to Cognitively Normal Individuals?
Grill, J. D., Johnson, D. K., & Burns, J. M. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.75 · Cited by 34 · see citing works
Lojo‐Seoane, C., Facal-Mayo, D., & Juncos‐Rabadán, O. (2012) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2012.02.006 · Cited by 32 · see citing works
Amyloid imaging and memory change for prediction of cognitive impairment
Resnick, S. M., & Sojkova, J. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt62 · Cited by 31 · see citing works
Cai, Y. Q., Shi, D., Lan, G., Chen, L., Jiang, Y., Zhou, L., Guo, T., & Initiative, A. D. N. (2024) · Neurology · doi:10.1212/wnl.0000000000209205 · Cited by 31 · see citing works
Batzu, L., Westman, E., & Pereira, J. B. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.012 · Cited by 30 · see citing works
Vaqué-Alcázar, L., Sala-Llonch, R., Valls-Pedret, C., Vidal-Piñeiro, D., Fernández-Cabello, S., Bargalló, N., Ros, E., & Bartrés-Faz, D. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9584-8 · Cited by 28 · see citing works
Ferreira, D., Falahati, F., Linden, C., Buckley, R. F., Ellis, K. A., Savage, G. R., Villemagne, V. L., Rowe, C. C., Ames, D. J., Simmons, A., et al. (2017) · Scientific Reports · doi:10.1038/srep44368 · Cited by 29 · see citing works
Self-citationFalcón, C., Tucholka, A., Monté, G. C., Cacciaglia, R., Operto, G., Rami, L., Gispert, J. D., & Molinuevo, J. L. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.04.016 · Cited by 29 · see citing works
Neuroanatomical and neurocognitive changes associated with subjective cognitive decline
Rivas‐Fernández, M. Á., Lindı́n, M., Zurrón, M., Dı́az, F., Lojo‐Seoane, C., Pereiro, A. X., & Galdo‐Álvarez, S. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1094799 · Cited by 29 · see citing works
Structural imaging outcomes in subjective cognitive decline: Community vs. clinical-based samples
Pini, L., & Wennberg, A. M. V. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111216 · Cited by 28 · see citing works
Almdahl, I. S., Lauridsen, C., Selnes, P., Kalheim, L. F., Coello, C. S., Gajdzik, B., Møller, I., Wettergreen, M., Grambaitė, R., Bjørnerud, A., et al. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00009 · Cited by 26 · see citing works
Zhan, Y., Initiative, A. D. N., Chen, K., Wu, X., Zhang, D., Zhang, J., Yao, L., & Guo, X. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142820 · Cited by 25 · see citing works
Regional age-related atrophy after screening for preclinical alzheimer disease
Koenig, L. N., LaMontagne, P., Glasser, M. F., Bateman, R. J., Holtzman, D. M., Yakushev, I. Y., Chhatwal, J. P., Day, G. S., Jack, C. R., Mummery, C. J., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.09.010 · Cited by 24 · see citing works
Benvenutto, A., Giusiano, B., Koric, L., Guériot, C., Didic, M., Felician, O., Guye, M., Guedj, E., & Ceccaldi, M. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180292 · Cited by 23 · see citing works
Subjective cognitive impairment: Towards early identification of Alzheimer disease
Ptacek, S. G., Eriksdotter, M., Jelić, V., Porta-Etessam, J., Kåreholt, I., & Palomo, S. M. (2016) · Neurología (English Edition) · doi:10.1016/j.nrleng.2013.02.011 · Cited by 23 · see citing works
Teipel, S. J., Cavedo, E., Weschke, S., Grothe, M. J., Rojkova, K., Fontaine, G., Dauphinot, L., Gonzalez-Escamilla, G., Potier, M.-C., Bertin, H., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.016 · Cited by 22 · see citing works
Nosheny, R. L., Insel, P. S., Mattsson, N., Tosun, D., Buckley, S. T., Truran, D., Schuff, N. W., Aisen, P. S. S., & Weiner, M. W. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.07.005 · Cited by 22 · see citing works
Parker, A. F., Ohlhauser, L., Scarapicchia, V., Smart, C. M., Szoeke, C., & Gawryluk, J. R. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215249 · Cited by 21 · see citing works
Self-citationSolé‐Padullés, C., Lladó, A., Bartrés‐Faz, D., Fortea, J., Sánchez‐Valle, R., Bosch, B., Antonell, A., Molinuevo, J. L., & Rami, L. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.12.001 · Cited by 19 · see citing works
Differential effects of sleep on brain structure and metabolism at the preclinical stages of AD
Stankeviciute, L. S., Falcón, C., Operto, G., García-Prat, M., Shekari, M., Iranzo, Á., Niñerola‐Baizán, A., Perissinotti, A., Minguillón, C., Fauria, K., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13102 · Cited by 18 · see citing works
Brain β-Amyloid and Atrophy in Individuals at Increased Risk of Cognitive Decline
Martikainen, I. K., Kemppainen, N. M., Johansson, J. J., Teuho, J., Helin, S., Liu, Y., Helisalmi, S., Soininen, H. S., Parkkola, R. K., Ngandu, T., et al. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5891 · Cited by 18 · see citing works
Canário, N., Jorge, L., Martins, R., Santana, I. J., & Castelo-Branco, M. S. (2022) · Communications Biology · doi:10.1038/s42003-022-03761-7 · Cited by 17 · see citing works
Self-citationEllis, K. A., Rainey‐Smith, S. R., Rembach, A., Macaulay, S. L., Villemagne, V. L., & Aibl research group (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.870136 · Cited by 17 · see citing works
Self-citationMatloff, W. J., Zhao, L., Ning, K., Conti, D. V., & Toga, A. W. (2019) · Alcohol · doi:10.1016/j.alcohol.2019.11.002 · Cited by 16 · see citing works
APOE-ε4-related differences in left thalamic microstructure in cognitively healthy adults
Mole, J. P., Fasano, F., Evans, J., Sims, R., Kidd, E., Aggleton, J. P., & Metzler-Baddeley, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-75992-9 · Cited by 15 · see citing works
- Authors
- Chételat, G., Villemagne, V. L., Pike, K. E., Baron, J.-C., Bourgeat, P., Jones, G., Faux, N. G., Ellis, K. A., Salvado, O., Szoeke, C., Martins, R. N., Ames, D., Masters, C. L., & Rowe, C. C.
- Affiliations
- Inserm (FR)
- Mental Health Research Institute (AU)
- University of Cambridge (GB)
- Commonwealth Scientific and Industrial Research Organisation (AU)
- Austin Health (AU)
- The University of Melbourne (AU)
- Edith Cowan University (AU)
- National Ageing Research Institute (AU)
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-08-25
- Volume
- 133
- Issue
- 11
- Pages
- 3349-3358
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2075668621
- Cited by
- 159
- References
- 41
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 8 · 2023: 6 · 2022: 5 · 2021: 10 · 2020: 10 · 2019: 11 · 2018: 13 · 2017: 13 · 2016: 8 · 2015: 8 · 2014: 15 · 2013: 17 · 2012: 8
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Commonwealth Scientific and Industrial Research Organisation
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
- Keywords
- amyloid-beta deposition, Alzheimer's disease, hippocampal volume, brain reserve, gray matter atrophy, mild cognitive impairment, subjective cognitive impairment, episodic memory, 11C-Pittsburgh compound B, amyloid PET
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Female, Heterozygote, Humans, Male, Organ Size, Temporal Lobe, Cohort Studies, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
